{
  "timestamp": "2025-07-27T21:41:32.862Z",
  "testInput": {
    "cagr": "12.5%",
    "marketSize": "2.8B",
    "directCompetitors": [
      "Enhertu",
      "Kadcyla",
      "Perjeta"
    ],
    "prvEligibility": "Eligible - Orphan Drug Designation",
    "nationalPriority": "High - Unmet Medical Need",
    "reviewTimelineMonths": "12",
    "peakRevenue2030": "1.8B",
    "total10YearRevenue": "12.5B",
    "peakMarketShare2030": "15%",
    "peakPatients2030": "150K",
    "avgSellingPrice": "$45K",
    "persistenceRate": "75%",
    "treatmentDuration": "18 months",
    "geographicSplit": "60% US / 40% Ex-US",
    "competitorPricing": [
      {
        "drugName": "Enhertu",
        "annualPrice": "$165K",
        "indication": "HER2+ Breast Cancer",
        "accessLevel": "Broad",
        "rationale": "FDA approved with broad payer coverage"
      }
    ],
    "pricingScenarios": [
      {
        "scenario": "Base Case",
        "usPrice": "$180K",
        "exUsPrice": "$120K",
        "grossToNet": "35%",
        "copay": "Yes",
        "access": "Yes",
        "genericYear": "Yr 8",
        "lossOfExclusivity": "65%",
        "rationale": "Competitive pricing with comprehensive access programs"
      }
    ],
    "strategicTailwindData": {
      "fdaDesignations": {
        "breakthroughTherapy": "Likely",
        "fastTrack": "Eligible",
        "orphanDrug": "Eligible",
        "priorityReview": "Likely",
        "rationale": "Unmet medical need in metastatic setting"
      }
    },
    "dealActivity": [
      {
        "assetName": "Enhertu",
        "buyer": "AstraZeneca",
        "developmentStage": "Phase 3",
        "dealPrice": "$6.9B",
        "dealDate": "2020-03-27",
        "rationale": "Major global co-development and commercialization deal"
      }
    ],
    "pipelineAnalysis": {
      "crowdingPercent": "12%",
      "competitiveThreats": [
        "ADC competition",
        "Novel HER2 inhibitors"
      ],
      "strategicFitRank": "85"
    }
  },
  "assessment": {
    "overallScore": 78.5,
    "categoryScores": {
      "factualAccuracy": {
        "score": 80,
        "confidence": 0.8,
        "reasoning": "Some numerical data lacks context, but overall accurate."
      },
      "scientificCoherence": {
        "score": 78,
        "confidence": 0.75,
        "reasoning": "Biological plausibility is sound, but clinical interpretation could be deeper."
      },
      "sourceCredibility": {
        "score": 70,
        "confidence": 0.65,
        "reasoning": "Insufficient primary sources and lack of peer-reviewed references."
      },
      "pharmaExpertise": {
        "score": 85,
        "confidence": 0.85,
        "reasoning": "Strong understanding of market access and competitive landscape."
      },
      "reasoningDepth": {
        "score": 75,
        "confidence": 0.75,
        "reasoning": "Causal relationships are present but lack depth in alternative scenarios."
      },
      "regulatoryCompliance": {
        "score": 80,
        "confidence": 0.8,
        "reasoning": "Good understanding of regulatory pathways but missing specific guidance references."
      },
      "marketIntelligence": {
        "score": 82,
        "confidence": 0.82,
        "reasoning": "Solid market analysis but growth projections need more justification."
      },
      "competitiveAnalysis": {
        "score": 77,
        "confidence": 0.78,
        "reasoning": "Competitor identification is adequate but lacks detailed threat assessment."
      }
    },
    "criticalIssues": [
      {
        "severity": "high",
        "category": "sourceCredibility",
        "description": "Lack of primary regulatory and clinical trial sources.",
        "impact": "Significantly reduces confidence in regulatory and clinical claims.",
        "suggestedFix": "Incorporate primary sources such as FDA.gov and clinicaltrials.gov."
      }
    ],
    "sourceValidation": {
      "totalSources": 15,
      "validSources": 12,
      "primarySources": 5,
      "recentSources": 10,
      "authoritativeSources": 8,
      "sourceQualityScore": 75,
      "missingCriticalSources": [
        "FDA.gov",
        "clinicaltrials.gov"
      ]
    },
    "confidenceLevel": 0.8,
    "shouldRetry": true,
    "retryPriority": "medium",
    "correctiveInstructions": "Include primary regulatory and clinical trial sources to enhance credibility.",
    "estimatedImprovementPotential": 10
  },
  "reviewTime": 11293,
  "reviewMetadata": {
    "model": "gpt-4o",
    "tokensUsed": 2016,
    "promptTokens": 1491,
    "completionTokens": 525
  },
  "overallScore": 78.5
}